Company research
Revance Therapeutics, Inc.
CIK 1479290Updated Sep 26, 2026
Filing activity
Latest filing
50 filings on record · SCHEDULE 13G/A, 15-12G, S-8 POS, POSASR, SCHEDULE 13G, 4.
Recent filings
SCHEDULE 13G/A - filed by Beryl Capital Management LLC regarding Revance Therapeutics, Inc.
SCHEDULE 13G/A - filed by JPMORGAN CHASE & CO regarding Revance Therapeutics, Inc.
15-12G filing
SCHEDULE 13G/A - filed by Palo Alto Investors LP regarding Revance Therapeutics, Inc.
S-8 POS filing
Show 5 more recent filings
Financials
FY 2023 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 478,454,000Source | 581,900,000Source | 531,163,000Source | 720,220,000Source |
| Property, Plant and Equipment, NetUSD | 17,225,000Source | 22,139,000Source | 24,661,000Source | 17,499,000Source |
| GoodwillUSD | 0Source | 77,175,000Source | 146,964,000Source | 146,964,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 9,808,000Source | 27,004,000Source | 55,334,000Source | 71,343,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 137,329,000Source | 108,965,000Source | 110,623,000Source | 333,558,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 27,676,000Source | 11,339,000Source | 3,348,000Source | 1,829,000Source |
| Inventory, NetUSD | 45,579,000Source | 18,325,000Source | 10,154,000Source | 5,876,000Source |
| Assets, CurrentUSD | 338,865,000Source | 374,727,000Source | 246,117,000Source | 450,003,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 11,145,000Source | 4,356,000Source | 7,544,000Source | 5,793,000Source |
| Operating Lease, Right-of-Use AssetUSD | 53,167,000Source | 39,223,000Source | 44,340,000Source | 29,632,000Source |
| Other Assets, NoncurrentUSD | 321,000Source | 1,687,000Source | 8,701,000Source | 1,334,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 630,058,000Source | 569,300,000Source | 462,692,000Source | 345,930,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 88,000Source | 82,000Source | 72,000Source | 69,000Source |
| Retained Earnings (Accumulated Deficit)USD | -2,078,360,000Source | -1,754,374,000Source | -1,397,952,000Source | -1,126,293,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 14,000Source | -374,000Source | -18,000Source | 0Source |
| Stockholders' Equity Attributable to ParentUSD | -151,604,000Source | 12,600,000Source | 68,471,000Source | 374,290,000Source |
| Additional Paid in Capital, Common StockUSD | 1,926,654,000Source | 1,767,266,000Source | 1,466,369,000Source | 1,500,514,000Source |
| Liabilities and EquityUSD | 478,454,000Source | 581,900,000Source | 531,163,000Source | 720,220,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 89,224,000Source | 75,682,000Source | 67,289,000Source | 60,964,000Source |
| Operating Lease, Liability, CurrentUSD | 5,703,000Source | 4,243,000Source | 4,746,000Source | 4,437,000Source |
| Accounts Payable, CurrentUSD | 13,809,000Source | 4,546,000Source | 10,603,000Source | 12,657,000Source |
| Operating Lease, Liability, NoncurrentUSD | 40,985,000Source | 34,182,000Source | 39,131,000Source | 27,146,000Source |
| Other Liabilities, NoncurrentUSD | 2,835,000Source | 1,485,000Source | 1,485,000Source | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 53,824,000Source | 59,357,000Source | 39,558,000Source | 32,938,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 253,900,000Source | 340,700,000Source | 225,100,000Source | 436,500,000Source |
| Deferred Tax Liabilities, NetUSD | 18,553,000Source | 11,644,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | — | 379,374,000Source | — | — |
| Long-term Debt, Current MaturitiesUSD | 2,500,000Source | — | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 426,595,000Source | — | — | — |
| Short-term InvestmentsUSD | 116,586,000Source | 231,742,000Source | 114,448,000Source | 102,947,000Source |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 11,375,000Source | 33,732,000Source | 19,853,000Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 47,813,000Source | 52,340,000Source | 43,434,000Source | 36,453,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 16,338,000Source | 7,990,000Source | 1,519,000Source | 1,736,000Source |
| Increase (Decrease) in InventoriesUSD | 14,910,000Source | 6,008,000Source | 4,278,000Source | 5,876,000Source |
| Increase (Decrease) in Accounts PayableUSD | 6,900,000Source | -5,448,000Source | -1,824,000Source | 4,425,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | 0Source | 0Source | -2,720,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -216,575,000Source | -193,548,000Source | -221,538,000Source | -178,502,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 109,740,000Source | -138,798,000Source | -29,665,000Source | 12,131,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 6,886,000Source | 3,210,000Source | 10,375,000Source | 259,304,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 8,216,000Source | 6,496,000Source | — | 8,441,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 136,567,000Source | 331,694,000Source | 29,869,000Source | 331,484,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | 0Source | 348,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 144,749,000Source | 115,017,000Source | 115,669,000Source | 337,003,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 15,090,000Source | 12,231,000Source | 5,031,000Source | 2,530,000Source |
| Additional Financial Items | ||||
| AmortizationUSD | 9,411,000Source | — | — | — |
| Share-based Payment Arrangement, ExpenseUSD | 49,187,000Source | 52,340,000Source | 43,434,000Source | 36,453,000Source |
| Amortization of Debt Issuance CostsUSD | 1,791,000Source | 1,662,000Source | 1,250,000Source | 333,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 2,397,000Source | 1,880,000Source | 1,250,000Source | 10,726,000Source |
| Amortization of Intangible AssetsUSD | 6,130,000Source | 28,331,000Source | 16,008,000Source | 7,200,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 253,900,000Source | 340,700,000Source | 225,100,000Source | 436,500,000Source |
| DepreciationUSD | — | — | — | 10,250,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | -52,000Source |
| GoodwillUSD | 0Source | 77,175,000Source | 146,964,000Source | 146,964,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | 16,000,000Source | — | — | — |
| Goodwill, Impairment LossUSD | 77,175,000Source | 69,789,000Source | 0Source | — |
| Impairment of Intangible Assets, Finite-livedUSD | 16,007,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | 300,000Source | 700,000Source | 0Source | -2,620,000Source |
| Net Income (Loss) Attributable to ParentUSD | -323,986,000Source | -356,422,000Source | -281,310,000Source | -282,089,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -323,986,000Source | -356,422,000Source | -281,310,000Source | — |
| Operating Costs and ExpensesUSD | 550,817,000Source | 474,523,000Source | 352,474,000Source | 288,487,000Source |
| Other Nonoperating Income (Expense)USD | -838,000Source | -2,181,000Source | -759,000Source | -592,000Source |
| Proceeds from Issuance of Common StockUSD | 100,183,000Source | 31,814,000Source | 21,706,000Source | 68,367,000Source |
| Proceeds from Stock Options ExercisedUSD | 15,289,000Source | 4,820,000Source | 16,688,000Source | 6,892,000Source |
| Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD | 52,331,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total RevenueUSD | 234,040,000Source | 132,565,000Source | 77,798,000Source | 15,325,000Source |
| Selling, General and Administrative ExpenseUSD | 297,732,000Source | 223,934,000Source | 198,821,000Source | 151,846,000Source |
| Operating Income (Loss)USD | -316,777,000Source | -341,958,000Source | -274,676,000Source | -273,162,000Source |
| Other Nonoperating Income (Expense)USD | -838,000Source | -2,181,000Source | -759,000Source | -592,000Source |
| Income Tax Expense (Benefit)USD | 300,000Source | 700,000Source | 0Source | -2,620,000Source |
| Net Income (Loss) Attributable to ParentUSD | -323,986,000Source | -356,422,000Source | -281,310,000Source | -282,089,000Source |
| Earnings Per Share, BasicUSD per share | -3.83Source | -4.9Source | -4.17Source | — |
| Earnings Per Share, DilutedUSD per share | -3.83Source | -4.9Source | -4.17Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 84,599,409Source | 72,713,340Source | 67,507,818Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 84,599,409Source | 72,713,340Source | 67,507,818Source | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 6,130,000Source | 28,331,000Source | 16,008,000Source | 7,200,000Source |
| Current Income Tax Expense (Benefit)USD | 300,000Source | 700,000Source | 0Source | 100,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 6,130,000Source | 27,847,000Source | — | — |
| Goodwill, Impairment LossUSD | 77,175,000Source | 69,789,000Source | 0Source | — |
| Income (Loss) Attributable to Parent, before TaxUSD | -323,686,000Source | -355,722,000Source | -281,310,000Source | -284,709,000Source |
| Interest ExpenseUSD | 19,356,000Source | 16,474,000Source | 6,273,000Source | 15,148,000Source |
| Interest Expense, DebtUSD | 17,534,000Source | 13,787,000Source | 6,281,000Source | 15,142,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -323,986,000Source | -356,422,000Source | -281,310,000Source | — |
| Operating Costs and ExpensesUSD | 550,817,000Source | 474,523,000Source | 352,474,000Source | 288,487,000Source |
| Research and Development ExpenseUSD | 79,410,000Source | 101,286,000Source | 116,255,000Source | 125,795,000Source |
| Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD | 52,331,000Source | — | — | — |